Post a Free Blog

Submit A Press Release

Thursday, March 28, 2024
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
-- Advertisement --spot_img
HomeBusinessCDC recommends mRNA Pfizer or Moderna booster shot over Johnson & Johnson's...

CDC recommends mRNA Pfizer or Moderna booster shot over Johnson & Johnson’s adenovirus vaccine

On Thursday, the Centers for Diseases Control and Prevention (CDC) has recommended that people should take either a Pfizer-BioNTech or a Moderna shot as a booster, when available. The recommendation was signed by Rochelle Walensky, the director of the CDC.

The new recommendation stated that “mRNA vaccines” were “preferred over the Janssen Covid-19 vaccine” in order to prevent the spread of Covid-19 in adults who were 18 years of age and above.

Members of the agency’s Advisory Committee on Immunization Practices had voted in favor of the recommendation. Dr. Walensky released the recommendation a short while after this vote. The committee voted in favor as the Food and Drug Administration (FDA) had updated the risk of rare but potentially life-threatening blood clots that have been linked to the vaccine by Johnson & Johnson (J & J) called the Janssen vaccine in the U.S.

Later on Thursday, the CDC also said that the supply of mRNA vaccine in the U.S. was in abundance and that there were almost 100 million doses available for immediate use. It also said that similar recommendations had been made in countries such as the U.K. and Canada.

The CDC said that the Janssen vaccine would be available for those who were not able to or not willing to receive an mRNA vaccine. They would still have access to the vaccine from J & J.

At least 54 among the millions who received the J & J single dose shot in the U.S. had suffered from blood clots and all of them were hospitalized. Thirty six of them were in intensive care. Nine of them have died. A majority of those who got blood clots were women aged 30 to 49. However, the number of blood clots formed as a result of the vaccine are comparably much lower than the blood clots that can form due to a COVID-19 infection.



Subscribe to get Latest News Updates

Latest News Articles

You may like more
more

Walgreens Boots Alliance Shares Gains 3 percent Following Q2 Results

Walgreens Boots Alliance (NASDAQ:WBA) shares rose more than 3%...

Home Depot to Buy SRS Distribution

Home Depot (NYSE:HD) announced its intention to purchase SRS...

Google code on Pinterest app suggests potential test of ad units, CWEB analysts say

Google and Pinterest might be testing a new partnership....

DraftKings Falls, NCAA Wants to Ban College Prop Bets. CWEB analysts issue Hold Rating on the stock.

Shares of DraftKings Inc.(DKNG) experienced a significant decline on...